BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martins D, Norris K. Combating diabetic nephropathy with drug therapy. Curr Diab Rep 2001;1:148-56. [PMID: 12643111 DOI: 10.1007/s11892-001-0027-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Liau C, Lee C, Sheu S, Ueng K, Chien K, Su T, Lai W, Lin M, Lin C, Lin C. Efficacy and Safety of Olmesartan in the Treatment of Mild-to-Moderate Essential Hypertension in Chinese Patients: . Clinical Drug Investigation 2005;25:473-9. [DOI: 10.2165/00044011-200525070-00006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
2 Mccarty MF. Adjuvant strategies for prevention of glomerulosclerosis. Medical Hypotheses 2006;67:1277-96. [DOI: 10.1016/j.mehy.2004.11.048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
3 Lea JP, Norris K, Agodoa L. The role of anemia management in improving outcomes for African-Americans with chronic kidney disease. Am J Nephrol 2008;28:732-43. [PMID: 18434712 DOI: 10.1159/000127981] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
4 Zhang X, He H, Liang D, Jiang Y, Liang W, Chi ZH, Ma J. Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice. Int J Mol Sci 2016;17:E1327. [PMID: 27529235 DOI: 10.3390/ijms17081327] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]